Apoptosis

, Volume 6, Issue 3, pp 183–190

Anti-apoptotic action of macrophage stimulating protein (MSP)

  • A. Danilkovitch-Miagkova
  • E. J. Leonard
Article

Abstract

MSP is a serum protein belonging to the plasminogen-related kringle domain protein family. In addition to macrophages, epithelial cells are also MSP targets. MSP is a multifunctional factor regulating cell adhesion and motility, growth and survival. MSP mediates its biological activities by activating a transmembrane receptor tyrosine kinase called RON in humans or SKT in mice. MSP can protect epithelial cells from apoptosis by activating two independent signals in the PI3-K/AKT or the MAPK pathway. The MAPK pathway mediates the MSP anti-apoptotic effect only if additional signaling pathways are activated through adhesion. This indicates that MSP receptors and integrins, the receptors mediating cell-matrix-dependent adhesion, can collaborate in promotion of cell survival. This adhesion-dependent pathway, which is essential for the MAPK-mediated anti-apoptotic effect, remains to be identified. A hypothesis that Stat3 might represent a key component of the adhesion-induced anti-apoptotic pathway is presented in this review.

adhesion apoptosis epithelial cells MSP signaling 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Leonard EJ, Skeel A. A serum protein that stimulates macrophage movement, chemotaxis and spreading. Exp Cell Res 1976; 102: 434-438.Google Scholar
  2. 2.
    Han S, Stuart LA, Degen SJ. Characterization of the DNF15S2 locus on human chromosome 3: Identification of a gene coding for four kringle domains with homology to hepatocyte growth factor. Biochemistry 1991; 30: 9768-9780.Google Scholar
  3. 3.
    Yoshimura T, Yuhki N, Wang MH, et al. Cloning, sequencing, and expression of human macrophage stimulating protein (MSP, MST1) confirms MSP as a member of the family of kringle proteins and locates the MSP gene on chromosome 3. J Biol Chem 1993; 268: 15461-15468.Google Scholar
  4. 4.
    Leonard EJ, Danilkovitch A. Macrophage stimulating protein. Adv Cancer Res 2000; 77: 139-167.Google Scholar
  5. 5.
    Donate LE, Gherardi E, Srinivasan N, et al. Molecular evolution and domain structure of plasminogen-related growth factors (HGF/SF and HGF1/MSP). Protein Sci 1994; 3: 2378-2394.Google Scholar
  6. 6.
    Comoglio PM, Tamagnone L, Boccaccio C. Plasminogen-related growth factor and semaphorin receptors: a gene superfamily controlling invasive growth. Exp Cell Res 1999; 253: 88-99.Google Scholar
  7. 7.
    Patthy L. Evolution of the proteases of blood coagulation and fibrinolysis by assembly from modules. Cell 1985; 41: 657-663.Google Scholar
  8. 8.
    Bezerra JA, Witte DP, Aronow BJ, Degen SJ. Hepatocyte-specific expression of the mouse hepatocyte growth factor-like protein. Hepatology 1993; 18: 394-399.Google Scholar
  9. 9.
    Wang MH, Yoshimura T, Skeel A, Leonard EJ. Proteolytic conversion of single chain precursor macrophage-stimulating protein to a biologically active heterodimer by contact enzymes of the coagulation cascade. J Biol Chem 1994; 269: 3436-3440.Google Scholar
  10. 10.
    Wang MH, Skeel A, Leonard EJ. Proteolytic cleavage and activation of pro-macrophage-stimulating protein by resident peritoneal macrophage membrane proteases. J Clin Invest 1996; 97: 720-727.Google Scholar
  11. 11.
    Wang MH, Ronsin C, Gesnel MC, et al. Identification of the ron gene product as the receptor for the human macrophage stimulating protein. Science 1994; 266: 117-119.Google Scholar
  12. 12.
    Wang MH, Iwama A, Skeel A, et al. The murine stk gene product, a transmembrane protein tyrosine kinase, is a receptor for macrophage-stimulating protein. Proc Natl Acad Sci USA 1995; 92: 3933-3937.Google Scholar
  13. 13.
    Ronsin C, Muscatelli F, Mattei MG, Breathnach R. A novel putative receptor protein tyrosine kinase of the met family. Oncogene 1993; 8: 1195-1202.Google Scholar
  14. 14.
    Iwama A, Okano K, Sudo T, et al. Molecular cloning of a novel receptor tyrosine kinase gene, STK, derived from enriched hematopoietic stem cells. Blood 1994; 83: 3160-3169.Google Scholar
  15. 15.
    Bottaro DP, Rubin JS, Faletto DL, et al. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 1991; 251: 802-804.Google Scholar
  16. 16.
    Huff JL, Jelinek MA, Borgman CA, et al. The protooncogene c-sea encodes a transmembrane protein-tyrosine kinase related to the Met/hepatocyte growth factor/scatter factor receptor. Proc Natl Acad Sci USA 1993; 90: 6140-6144.Google Scholar
  17. 17.
    Gaudino G, Follenzi A, Naldini L, et al. RON is a heterodimeric tyrosine kinase receptor activated by the HGF homologue MSP. EMBO J 1994; 13: 3524-3532.Google Scholar
  18. 18.
    Skeel A, Leonard EJ. Action and target cell specificity of human macrophage-stimulating protein (MSP). J Immunol 1994; 152: 4618-4623.Google Scholar
  19. 19.
    Kurihara N, Iwama A, Tatsumi J, et al. Macrophage-stimulating protein activates STK receptor tyrosine kinase on osteoclasts and facilitates bone resorption by osteoclast-like cells. Blood 1996; 87: 3704-3710.Google Scholar
  20. 20.
    Wang MH, Dlugosz AA, Sun Y, et al. Macrophage-stimulating protein induces proliferation and migration of murine keratinocytes. Exp Cell Res 1996; 226: 39-46.Google Scholar
  21. 21.
    Wang MH, Montero-Julian FA, Dauny I, Leonard EJ. Requirement of phosphatidylinositol-3 kinase for epithelial cell migration activated by human macrophage stimulating protein. Oncogene 1996; 13: 2167-2175.Google Scholar
  22. 22.
    Danilkovitch A, Skeel A, Leonard EJ. Macrophage stimulating protein-induced epithelial cell adhesion is mediated by a PI3-K-dependent, but FAK-independent mechanism. Exp Cell Res 1999; 248: 575-582.Google Scholar
  23. 23.
    Banu N, Price DJ, London R, et al. Modulation of megakaryocytopoiesis by human macrophage-stimulating protein, the ligand for the RON receptor. J Immunol 1996; 156: 2933-2940.Google Scholar
  24. 24.
    Iwama A, Yamaguchi N, Suda T. STK/RON receptor tyrosine kinase mediates both apoptotic and growth signals via the multifunctional docking site conserved among the HGF receptor family. EMBO J 1996; 15: 5866-5875.Google Scholar
  25. 25.
    Danilkovitch A, Donley S, Skeel A, Leonard EJ. Two independent signaling pathways mediate the antiapoptotic action of macrophage-stimulating protein on epithelial cells. Mol Cell Biol 2000: 20: 2218-2227.Google Scholar
  26. 26.
    Frisch SM, Francis H. Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol 1994; 124: 619-626.Google Scholar
  27. 27.
    Ruoslahti E, Reed JC. Anchorage dependence, integrins, and apoptosis. Cell 1994; 77: 477-478.Google Scholar
  28. 28.
    Frisch SM, Ruoslahti E. Integrins and anoikis. Curr Opin Cell Biol 1997; 9: 701-706.Google Scholar
  29. 29.
    Meredith JEJ, Fazeli B, Schwartz MA. The extracellular matrix as a cell survival factor. Mol Biol Cell 1993; 4: 953-961.Google Scholar
  30. 30.
    Adams JC, Watt FM. Regulation of development and differentiation by the extracellular matrix. Development 1993; 117: 1183-1198.Google Scholar
  31. 31.
    Freedman VH, Shin SI. Cellular tumorigenicity in nude mice: Correlation with cell growth in semi-solid medium. Cell 1974; 3: 355-359.Google Scholar
  32. 32.
    Schwartz MA. Integrins, oncogenes, and anchorage independence. J Cell Biol 1997; 139: 575-578.Google Scholar
  33. 33.
    Stoker M, O'Neill C, Berryman S, Waxman V. Anchorage and growth regulation in normal and virus-transformed cells. Int J Cancer 1968; 3: 683-693.Google Scholar
  34. 34.
    Hynes RO. Integrins: Versatility, modulation, and signaling in cell adhesion. Cell 1992; 69: 11-25.Google Scholar
  35. 35.
    Frisch SM, Vuori K, Ruoslahti E, Chan-Hui PY. Control of adhesion-dependent cell survival by focal adhesion kinase. J Cell Biol 1996; 134: 793-799.Google Scholar
  36. 36.
    Giancotti FG. Integrin signaling: Specificity and control of cell survival and cell cycle progression. Curr Opin Cell Biol 1997; 9: 691-700.Google Scholar
  37. 37.
    Guillonneau X, Bryckaert M, Launay-Longo C, et al. Endogenous FGF1-induced activation and synthesis of extracellular signal-regulated kinase 2 reduce cell apoptosis in retinal-pigmented epithelial cells. J Biol Chem 1998; 273: 22367-22373.Google Scholar
  38. 38.
    Fan S, Wang JA, Yuan RQ, et al. Scatter factor protects epithelial and carcinoma cells against apoptosis induced by DNA damaging agents. Oncogene 1998; 17: 131-141.Google Scholar
  39. 39.
    Yao R, Cooper GM. Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor. Science 1995; 267: 2003-2006.Google Scholar
  40. 40.
    Bozzo C, Bellomo G, Silengo L, et al. Soluble integrin ligands and growth factors independently rescue neuroblastoma cells from apoptosis under nonadherent conditions. Exp Cell Res 1997; 237: 326-337.Google Scholar
  41. 41.
    Valentinis B, Reiss K, Baserga R. Insulin-like growth factor-I-mediated survival from anoikis: Role of cell aggregation and focal adhesion kinase. J Cell Physiol 1998; 176: 648-657.Google Scholar
  42. 42.
    Nanney LB, Skeel A, Luan J, et al. Proteolytic cleavage and activation of pro-macrophage-stimulating protein and upregulation of its receptor in tissue injury. J Invest Dermatol 1998; 111: 573-581.Google Scholar
  43. 43.
    Gaudino G, Avantaggiato V, Follenzi A, et al. The protooncogene RON is involved in development of epithelial, bone and neuro-endocrine tissues. Oncogene 1995; 11: 2627-2637.Google Scholar
  44. 44.
    Waltz SE, McDowell SA, Muraoka RS, et al. Functional characterization of domains contained in hepatocyte growth factor-like protein. J Biol Chem 1997; 272: 30526-30537.Google Scholar
  45. 45.
    Danilkovitch A, Leonard EJ. Kinases involved in MSP/RON signaling. J Leukoc Biol 1999; 65: 345-348.Google Scholar
  46. 46.
    Hanks SK, Polte TR. Signaling through focal adhesion kinase. Bioessays 1997; 19: 137-145.Google Scholar
  47. 47.
    Kumar CC. Signaling by integrin receptors. Oncogene 1998; 17: 1365-1373.Google Scholar
  48. 48.
    Giancotti FG, Ruoslahti E. Integrin signaling. Science 1999; 285: 1028-1032.Google Scholar
  49. 49.
    Folkman J, Moscona A. Role of cell shape in growth control. Nature 1978; 273: 345-349.Google Scholar
  50. 50.
    Iglehart JD, Kraus MH, Langton BC, et al. Increased erbB-2 gene copies and expression in multiple stages of breast cancer. Cancer Res 1990; 50: 6701-6707.Google Scholar
  51. 51.
    Kern JA, Schwartz DA, Nordberg JE, et al. p185neu expression in human lung adenocarcinomas predicts shortened survival. Cancer Res 1990; 50: 5184-5187.Google Scholar
  52. 52.
    Potapova O, Fakhrai H, Baird S, Mercola D. Platelet-derived growth factor-B/v-sis confers a tumorigenic and metastatic phenotype to human T98G glioblastoma cells. Cancer Res 1996; 56: 280-286.Google Scholar
  53. 53.
    Resnicoff M, Abraham D, Yutanawiboonchai W, et al. The insulin-like growth factor I receptor protects tumor cells from apoptosis in vivo. Cancer Res 1995; 55: 2463-2469.Google Scholar
  54. 54.
    Baserga R, Hongo A, Rubini M, et al. The IGF-I receptor in cell growth, transformation and apoptosis. Biochim Biophys Acta 1997; 1332: F105-F126.Google Scholar
  55. 55.
    Resnicoff M, Burgaud JL, Rotman HL, et al. Correlation between apoptosis, tumorigenesis, and levels of insulin-like growth factor I receptors. Cancer Res 1995; 55: 3739-3741.Google Scholar
  56. 56.
    Werner H, Le Roith D. The insulin-like growth factor-I receptor signaling pathways are important for tumorigenesis and inhibition of apoptosis. Crit Rev Oncog 1997; 8: 71-92.Google Scholar
  57. 57.
    Maggiora P, Marchio S, Stella MC, et al. Overexpression of the RON gene in human breast carcinoma. Oncogene 1998; 16: 2927-2933.Google Scholar
  58. 58.
    Collesi C, Santoro MM, Gaudino G, Comoglio PM. A splicing variant of the RON transcript induces constitutive tyrosine kinase activity and an invasive phenotype [published erratum appears in Mol Cell Biol 1997 Jan;17(1):528]. Mol Cell Biol 1996; 16: 5518-5526.Google Scholar
  59. 59.
    Santoro MM, Collesi C, Grisendi S, et al. Constitutive activation of the RON gene promotes invasive growth but not transformation [published erratum appears in Mol Cell Biol 1997 Mar;17(3):1758]. Mol Cell Biol 1996; 16: 7072-7083.Google Scholar
  60. 60.
    Bellacosa A, Testa JR, Staal SP, Tsichlis PN. A retroviral oncogene, akt, encoding a serine-threonine kinase containing an SH2-like region. Science 1991; 254: 274-277.Google Scholar
  61. 61.
    Khwaja A, Rodriguez-Viciana P, Wennstrom S, et al. Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway. EMBO J 1997; 16: 2783-2793.Google Scholar
  62. 62.
    Kulik G, Weber MJ. Akt-dependent and-independent survival signaling pathways utilized by insulin-like growth factor I. Mol Cell Biol 1998; 18: 6711-6718.Google Scholar
  63. 63.
    Le Gall M, Grall D, Chambard JC, et al. An anchorage-dependent signal distinct from p42/44 MAP kinase activation is required for cell cycle progression. Oncogene 1998; 17: 1271-1277.Google Scholar
  64. 64.
    Lenormand P, Brondello JM, Brunet A, Pouyssegur J. Growth factor-induced p42/p44 MAPK nuclear translocation and retention requires both MAPK activation and neosynthesis of nuclear anchoring proteins. J Cell Biol 1998; 142: 625-633.Google Scholar
  65. 65.
    Brunet A, Roux D, Lenormand P, et al. Nuclear translocation of p42/p44 mitogen-activated protein kinase is required for growth factor-induced gene expression and cell cycle entry. EMBO J 1999; 18: 664-674.Google Scholar
  66. 66.
    Danilkovitch-Miagkova A, Angeloni D, Skeel A, et al. Integrin-mediated RON growth factor receptor phosphorylation requires tyrosine kinase activity of both the receptor and c-Src. J Biol Chem 2000; 275: 14783-14786.Google Scholar
  67. 67.
    Stahl N, Farruggella TJ, Boulton TG, et al. Choice of STATs and other substrates specified by modular tyrosine-based motifs in cytokine receptors. Science 1995; 267: 1349-1353.Google Scholar
  68. 68.
    Wegenka UM, Buschmann J, Lutticken C, et al. Acute-phase response factor, a nuclear factor binding to acute-phase response elements, is rapidly activated by interleukin-6 at the posttranslational level. Mol. Cell Biol. 1993; 13: 276-288.Google Scholar
  69. 69.
    Akira S. IL-6-regulated transcription factors. Int J Biochem Cell Biol 1997; 29: 1401-1418.Google Scholar
  70. 70.
    Hirano T, Ishihara K, Hibi M. Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors. Oncogene 2000; 19: 2548-2556.Google Scholar
  71. 71.
    Leaman DW, Leung S, Li X, Stark GR. Regulation of STAT-dependent pathways by growth factors and cytokines. FASEB J 1996; 10: 1578-1588.Google Scholar
  72. 72.
    Schindler C, Darnell JEJ. Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Annu Rev Biochem 1995; 64: 621-651.Google Scholar
  73. 73.
    Bowman T, Garcia R, Turkson J, Jove R. STATs in oncogenesis. Oncogene 2000; 19: 2474-2488.Google Scholar
  74. 74.
    Bromberg JF, Wrzeszczynska MH, Devgan G, et al. Stat3 as an oncogene [published erratum appears in Cell 1999 Oct 15; 99 (2): 239]. Cell 1999; 98: 295-303.Google Scholar
  75. 75.
    Shuai K. Modulation of STAT signaling by STAT-interacting proteins. Oncogene 2000; 19: 2638-2644.Google Scholar
  76. 76.
    Darnell JEJ. STATs and gene regulation. Science 1997; 277: 1630-1635.Google Scholar
  77. 77.
    Wen Z, Zhong Z, Darnell JEJ. Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell 1995; 82: 241-250.Google Scholar
  78. 78.
    Schaeffer HJ, Weber MJ. Mitogen-activated protein kinases: Specific messages from ubiquitous messengers. Mol Cell Biol 1999; 19: 2435-2444.Google Scholar
  79. 79.
    Coucouvanis, E. and Martin GR. Signals for death and survival: A two-step mechanism for cavitation in the vertebrate embryo. Cell 1995; 83: 279-287.Google Scholar
  80. 80.
    Polakowska RR, Piacentini M, Bartlett R, et al. Apoptosis in human skin development: Morphogenesis, periderm, and stem cells. Dev Dyn 1994; 199: 176-188.Google Scholar
  81. 81.
    Hall PA, Coates PJ, Ansari B, Hopwood D. Regulation of cell number in the mammalian gastrointestinal tract: The importance of apoptosis. J Cell Sci 1994; 107: 3569-3577.Google Scholar
  82. 82.
    Boudreau N, Sympson CJ, Werb Z, Bissell MJ. Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix. Science 1995; 267: 891-893.Google Scholar

Copyright information

© Kluwer Academic Publishers 2001

Authors and Affiliations

  • A. Danilkovitch-Miagkova
    • 1
  • E. J. Leonard
    • 2
  1. 1.Section of Immunopathology, Laboratory of ImmunobiologyNational Cancer Institute, FrederickUSA
  2. 2.Section of Immunopathology, Laboratory of ImmunobiologyNational Cancer Institute, FrederickUSA

Personalised recommendations